Aura Biosciences (AURA) Competitors $6.15 +0.08 (+1.32%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$6.14 -0.01 (-0.08%) As of 05/2/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AURA vs. BGM, AUPH, ETNB, WVE, XFOR, ELVN, COLL, PHVS, SYRE, and MLYSShould you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Qilian International Holding Group (BGM), Aurinia Pharmaceuticals (AUPH), 89bio (ETNB), Wave Life Sciences (WVE), X4 Pharmaceuticals (XFOR), Enliven Therapeutics (ELVN), Collegium Pharmaceutical (COLL), Pharvaris (PHVS), Spyre Therapeutics (SYRE), and Mineralys Therapeutics (MLYS). These companies are all part of the "pharmaceutical products" industry. Aura Biosciences vs. Qilian International Holding Group Aurinia Pharmaceuticals 89bio Wave Life Sciences X4 Pharmaceuticals Enliven Therapeutics Collegium Pharmaceutical Pharvaris Spyre Therapeutics Mineralys Therapeutics Qilian International Holding Group (NASDAQ:BGM) and Aura Biosciences (NASDAQ:AURA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends. Which has preferable earnings and valuation, BGM or AURA? Qilian International Holding Group has higher revenue and earnings than Aura Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQilian International Holding Group$25.10M45.32-$1.44MN/AN/AAura BiosciencesN/AN/A-$76.41M-$1.75-3.51 Do analysts rate BGM or AURA? Aura Biosciences has a consensus target price of $22.75, suggesting a potential upside of 269.92%. Given Aura Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Aura Biosciences is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Do insiders & institutionals believe in BGM or AURA? 96.8% of Aura Biosciences shares are owned by institutional investors. 58.7% of Qilian International Holding Group shares are owned by company insiders. Comparatively, 5.4% of Aura Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk & volatility, BGM or AURA? Qilian International Holding Group has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Aura Biosciences has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Does the MarketBeat Community believe in BGM or AURA? Aura Biosciences received 26 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformQilian International Holding GroupN/AN/AAura BiosciencesOutperform Votes2661.90% Underperform Votes1638.10% Is BGM or AURA more profitable? Qilian International Holding Group's return on equity of 0.00% beat Aura Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Qilian International Holding GroupN/A N/A N/A Aura Biosciences N/A -41.57%-36.43% Does the media prefer BGM or AURA? In the previous week, Aura Biosciences had 1 more articles in the media than Qilian International Holding Group. MarketBeat recorded 3 mentions for Aura Biosciences and 2 mentions for Qilian International Holding Group. Qilian International Holding Group's average media sentiment score of 0.93 beat Aura Biosciences' score of 0.75 indicating that Qilian International Holding Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Qilian International Holding Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aura Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQilian International Holding Group and Aura Biosciences tied by winning 7 of the 14 factors compared between the two stocks. Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AURA vs. The Competition Export to ExcelMetricAura BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$308.88M$2.97B$5.55B$8.04BDividend YieldN/A1.87%5.09%4.22%P/E Ratio-3.5530.5222.6918.83Price / SalesN/A494.70404.28106.72Price / CashN/A168.6838.1834.62Price / Book1.343.216.794.33Net Income-$76.41M-$72.35M$3.22B$247.97M7 Day Performance14.31%13.48%3.37%3.18%1 Month Performance7.71%12.33%6.95%8.13%1 Year Performance-22.05%-23.51%16.13%5.01% Aura Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AURAAura Biosciences2.1228 of 5 stars$6.15+1.3%$22.75+269.9%-20.8%$308.88MN/A-3.5550Upcoming EarningsShort Interest ↑News CoverageBGMQilian International Holding GroupN/A$11.27+1.6%N/AN/A$1.10B$25.10M0.00298News CoverageAUPHAurinia Pharmaceuticals2.672 of 5 stars$8.00-2.2%$11.50+43.8%+58.8%$1.09B$235.13M-53.33300Positive NewsETNB89bio3.0472 of 5 stars$7.40+6.6%$27.25+268.2%-1.5%$1.08BN/A-2.5440Earnings ReportUpcoming EarningsAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsGap UpWVEWave Life Sciences4.3231 of 5 stars$6.83+1.5%$22.18+224.8%+37.8%$1.05B$108.30M-6.15240Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageXFORX4 Pharmaceuticals4.0839 of 5 stars$5.34-6.3%$85.00+1,491.8%-88.5%$927.36M$2.56M-59.3380Earnings ReportAnalyst ForecastStock SplitAnalyst RevisionNews CoverageGap UpHigh Trading VolumeELVNEnliven Therapeutics2.3164 of 5 stars$18.91+3.8%$40.33+113.3%-2.3%$926.67MN/A-9.9550News CoveragePositive NewsGap DownCOLLCollegium Pharmaceutical3.9849 of 5 stars$26.87+0.3%$43.60+62.3%-26.3%$904.19M$631.45M11.58210Upcoming EarningsNews CoveragePHVSPharvaris2.2087 of 5 stars$17.06+1.3%$42.67+150.1%-21.9%$892.07MN/A-6.0930Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeSYRESpyre Therapeutics1.9539 of 5 stars$14.67+3.8%$49.57+237.9%-58.3%$884.25M$890,000.00-1.96100Upcoming EarningsNews CoveragePositive NewsMLYSMineralys Therapeutics2.4595 of 5 stars$13.56+1.6%$33.00+143.4%+17.8%$879.72MN/A-3.7328Upcoming EarningsShort Interest ↑News Coverage Related Companies and Tools Related Companies Qilian International Holding Group Competitors Aurinia Pharmaceuticals Competitors 89bio Competitors Wave Life Sciences Competitors X4 Pharmaceuticals Competitors Enliven Therapeutics Competitors Collegium Pharmaceutical Competitors Pharvaris Competitors Spyre Therapeutics Competitors Mineralys Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AURA) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AURA Stock Free AURA Stock Alerts